⌘K
Loading ticker…
PMV Pharmaceuticals, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, PMV Pharmaceuticals, Inc (PMVP) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.8%, relative volume 0.58×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
24 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PMVP is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.4% / -8.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PMVP is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $563K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PMVP Jan avg: -17.13% median: -9.78% win: 0% σ: 17.77% n: 4 2022-04-12 → 2026-05-29 | PMVP Feb avg: 11.73% median: 0.80% win: 50% σ: 31.25% n: 4 2022-04-12 → 2026-05-29 | PMVP Mar avg: -22.36% median: -23.75% win: 0% σ: 10.96% n: 4 2022-04-12 → 2026-05-29 | PMVP Apr avg: -4.72% median: -3.35% win: 40% σ: 15.88% n: 5 2022-04-12 → 2026-05-29 | PMVP May avg: -5.33% median: -11.29% win: 40% σ: 14.02% n: 5 2022-04-12 → 2026-05-29 | PMVP Jun avg: 11.97% median: 18.86% win: 75% σ: 15.42% n: 4 2022-04-12 → 2026-05-29 (current) | PMVP Jul avg: 11.45% median: 4.69% win: 100% σ: 15.04% n: 4 2022-04-12 → 2026-05-29 | PMVP Aug avg: -0.83% median: -3.42% win: 25% σ: 7.84% n: 4 2022-04-12 → 2026-05-29 | PMVP Sep avg: -8.64% median: -9.80% win: 0% σ: 7.34% n: 4 2022-04-12 → 2026-05-29 | PMVP Oct avg: -15.46% median: 2.08% win: 75% σ: 40.13% n: 4 2022-04-12 → 2026-05-29 | PMVP Nov avg: 6.43% median: -3.50% win: 25% σ: 31.10% n: 4 2022-04-12 → 2026-05-29 | PMVP Dec avg: 2.61% median: -6.05% win: 25% σ: 22.08% n: 4 2022-04-12 → 2026-05-29 |